The presence of polycyclic aromatic hydrocarbons (PAHs) in air particles and estimation of the respiratory deposition flux.

Polycyclic aromatic hydrocarbons (PAHs) in the atmospheric particles constitute a topic of growing health concern. This study aims to calculate PAH concentrations, identify the source, assess the health risk from exposure to carcinogenic PAHs, and the respiratory deposition flux. PM10 and PM2.5 were collected in September 2019 in the urban, semi-urban, and semi-urban-industrial areas of Kuala Lumpur, Batu Pahat, and Bukit Rambai, respectively. A total of 18 PAHs from PM10 and 17 PAHs from PM2.5 were extracted using dichloromethane and determined using gas chromatography coupled with a flame ionization detector (GC-FID). The health risk assessment (HRA) calculated included B[a]P equivalent (B[a]Peq), lifetime lung cancer risk (LLCR), incremental lifetime cancer risk (ILCR), and respiratory deposition dose (RDD). The results show PAHs in PM10 recorded in Kuala Lumpur (DBKL), Batu Pahat (UTHM), and Bukit Rambai are 9.91, 8.45, and 9.57 ng/m3, respectively. The average PAHs in PM2.5 at the three sampling sites are 11.65, 9.68, and 9.37 ng/m3, respectively. The major source of PAHs obtained from the DRs indicates pyrogenic activities for both particle sizes. For PM10, the total B[a]Peq in DBKL, UTHM, and Bukit Rambai were 1.97, 1.82, and 2.32 ng/m3, respectively. For PM2.5 samples, the total B[a]Peq in DBKL, UTHM, and Bukit Rambai were 2.80, 2.33, and 2.57 ng/m3, respectively. The LLCR and ILCR show low to moderate risk for all age groups. The RDD of adults and adolescents is highest in both PM10 and PM2.5, followed by children, toddlers, and infants. Overall, we perceive that adults and adolescents living in the urban area of Kuala Lumpur are at the highest risk for respiratory health problems because of prolonged exposure to PAHs in PM10 and PM2.5, followed by children, toddlers, and infants.

Global health diplomacy in Iraq: international relations outcomes of multilateral tuberculosis programmes.

BACKGROUND: International development programmes, including global health interventions, have the capacity to make important implicit and explicit benefits to diplomatic and international relations outcomes. Conversely, in the absence of awareness of these implications, such programmes may generate associated threats. Due to heightened international tensions in conflict and post-conflict settings, greater attention to diplomatic outcomes may therefore be necessary. We examine related 'collateral' effects of Global Fund-supported tuberculosis programmes in Iraq. METHODS: During site visits to Iraq conducted during 2012 and 2013 on behalf of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on-site service delivery evaluations, unstructured interviews with clinical and operational staff, and programme documentary review of Global Fund-supported tuberculosis treatment and care programmes were conducted. During this process, a range of possible external or collateral international relations and diplomatic effects of global health programmes were assessed according to predetermined criteria. RESULTS: A range of positive diplomatic and international relations effects of Global Fund-supported programmes were observed in the Iraq setting. These included (1) geo-strategic accessibility and coverage; (2) provisions for programme sustainability and alignment; (3) contributions to nation-building and peace-keeping initiatives; (4) consistent observation of social, cultural and religious norms in intervention selection; and (5) selection of the most effective and cost-effective tuberculosis treatment and care interventions. CONCLUSION: Investments in global health programmes have valuable diplomatic, as well as health-related, outcomes, associated with their potential to prevent, mitigate or reverse international tension and hostility in conflict and post-conflict settings, provided that they adhere to appropriate criteria. The associated international presence in such regions may also contribute to peace-keeping efforts. Global health programmes may frequently produce a wider range of 'collateral benefits' that conventional monitoring and evaluation systems should be expanded to assess, in keeping with contemporary efforts to leverage development programmes from a 'global health diplomacy' perspective.